Should You Buy Contineum Therapeutics Inc (CTNM) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast CTNM stock price to rise
7 Analyst Rating
Wall Street analysts forecast CTNM stock price to rise
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 11.860
Low
14
Averages
18.6
High
22
Current: 11.860
Low
14
Averages
18.6
High
22
Morgan Stanley
Equal Weight
maintain
$14 -> $16
AI Analysis
2026-05-14
Reason
Morgan Stanley
Price Target
$14 -> $16
AI Analysis
2026-05-14
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Contineum to $16 from $14 and keeps an Equal Weight rating on the shares.
Baird
Charles Moore
Outperform
maintain
$14 -> $20
2026-03-06
Reason
Baird
Charles Moore
Price Target
$14 -> $20
2026-03-06
maintain
Outperform
Reason
Baird analyst Charles Moore raised the firm's price target on Contineum to $20 from $14 and keeps an Outperform rating on the shares. The firm updated its model following Q4 results and ahead of three clinical catalysts in 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CTNM
